10 studies were found.

1.		Completed	Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination Condition: HIV Infections
2.		Suspended	A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs Condition: HIV Infections
3.		No longer recruiting	A Comparison of Emtricitabine and Stavudine Used with Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs Condition: HIV Infections
4.		Recruiting	Emtricitabine Given Once A Day with Other Anti-HIV Drugs in Children with HIV Condition: HIV Infections
5.		Completed	A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive Condition: HIV Infections
6.		Terminated	The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors Condition: HIV Infections
7.		Terminated	The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined with MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors Condition: HIV Infections
8.		No longer recruiting	A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus. Condition: Hepatitis B
9.		Completed	A Study of MKC-442 in Combination with Other Anti-HIV Drugs Condition: HIV Infections
10.		Completed	A Study of MKC-442 in HIV-Positive Patients Condition: HIV Infections